|
ANIP | Ani Pharmaceuticals Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.35 |
| Leverage | 62.46% |
| Market Cap | $ 1.5B |
| PE | 19.88 |
| Dividend Yield | 0.00% |
| Profit | $ 77.6m |
| Margin | 8.80% |
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.